Related Experiment Video
Updated: Feb 4, 2026

In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
Neurologic Events in Continuous-Flow Left Ventricular Assist Devices
Ajay Kadakkal1, Samer S Najjar2
1Advanced Heart Failure Program, MedStar Heart and Vascular Institute, MedStar Washington Hospital Center, 110 Irving Street, Northwest Room 1F-1222, Washington, DC 20010, USA.
Abstract:
Although the growing use of continuous-flow left ventricular assist devices (LVADs) has improved the survival and quality of life of patients with stage D heart failure, ischemic and hemorrhagic cerebrovascular accidents remain one of the most-feared complications of this therapy and a significant source of disability, morbidity, and mortality. In this article, the authors aim to summarize the current data regarding the incidence/prevalence of both ischemic and hemorrhagic stroke in patients with continuous-flow LVADs, compare axial and centrifugal devices, and discuss the major risk factors for neurologic events that have been identified.
Related Concept Videos
Integration of Synaptic Events
Continuing Care
Continuity of a Function
Continuity Equation
The mass flow rate is expressed as:
Continuity Equation
Equation of Continuity

